Mission Cancer + Blood

Des Moines, Iowa 50314

1 studies enrolling now · 3 studies all time

What they study most

MF, Myelofibrosis, Polycythemia Vera, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis, Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Studies at this site

• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL) — Withdrawn before enrolling
• A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera — Running, not enrolling